November 04, 2026 at 02:06 PM UTC
Lyell Immunopharma, Inc. reports unregistered equity sale
Lyell Immunopharma, Inc. filed an 8-K covering an unregistered sale of equity securities. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 04, 2026 at 02:05 PM UTC
Open official source